Oncotarget

Research Papers:

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

PDF |  Full Text  |  Supplementary Files  |  How to cite

Oncotarget. 2019; 10:4894-4906. https://doi.org/10.18632/oncotarget.27122

Metrics: PDF 1398 views  |   Full Text 2725 views  |   ?  

Tengpeng Hu, Terkild Brink Buus, Thorbjørn Krejsgaard, Anneline Nansen, Betina Kerstin Lundholt, Pieter Spee, Simon Fredholm, David Leander Petersen, Edda Blümel, Maria Gluud, Madalena N. Monteiro, Andreas Willerslev-Olsen, Mads Hald Andersen, Per thor Straten, Özcan Met, Veronica Stolearenco, Hanne Fogh, Robert Gniadecki, Claudia Nastasi, Thomas Litman, Anders Woetmann, Lise Mette Rahbek Gjerdrum and Niels Ødum _

Abstract

Tengpeng Hu1, Terkild Brink Buus1, Thorbjørn Krejsgaard1, Anneline Nansen2, Betina Kerstin Lundholt2, Pieter Spee3, Simon Fredholm1, David Leander Petersen1, Edda Blümel1, Maria Gluud1, Madalena N. Monteiro1, Andreas Willerslev-Olsen1, Mads Hald Andersen1,4, Per thor Straten1,4, Özcan Met1,4, Veronica Stolearenco1, Hanne Fogh5, Robert Gniadecki5, Claudia Nastasi1, Thomas Litman1, Anders Woetmann1, Lise Mette Rahbek Gjerdrum6 and Niels Ødum1

1 LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

2 Department of Molecular Pharmacology, Zealand Pharma A/S, Glostrup, Denmark

3 PS Pharmaconsult, Allerød, Denmark

4 Center for Cancer Immune Therapy, Department of Hematology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark

5 Department of Dermatology, Copenhagen University Hospital at Bispebjerg, Copenhagen, Denmark

6 Department of Pathology, Zealand University Hospital, Roskilde, Denmark

Correspondence to:

Niels Ødum,email: ndum@sund.ku.dk

Keywords: Sézary syndrome; Kv1.3 channel; ShK; cutaneous T-cell lymphoma; cancer

Received: March 11, 2019     Accepted: July 15, 2019     Published: August 06, 2019

ABSTRACT

The voltage-gated potassium channel Kv1.3 (KCNA3) is expressed by a subset of chronically activated memory T cells and plays an important role in their activation and proliferation. Here, we show that primary malignant T cells isolated from patients with Sézary syndrome (SS) express Kv1.3 and are sensitive to potent Kv1.3 inhibitors ShK and Vm24, but not sensitive to a less potent inhibitor [N17A/F32T]-AnTx. Kv1.3 blockade inhibits CD3/CD28-induced proliferation and IL-9 expression by SS cells in a concentration-dependent manner. In parallel, CD3/CD28-mediated CD25 induction is inhibited, whereas Kv1.3 blockade has no effect on apoptosis or cell death as judged by Annexin V and PI staining. In conclusion, we provide the first evidence that malignant T cells in SS express functional Kv1.3 channels and that Kv1.3 blockade inhibits activation-induced proliferation as well as cytokine and cytokine receptor expression in malignant T cells, suggesting that Kv1.3 is a potential target for therapy in SS.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27122